UK-based charity, Parkinson’s UK is set to provide more than $1million in funding to US biotech company, Neurolixis, to accelerate the...

Parkinson’s UK is pleased to announce that it has agreed to provide up to £320,000 additional funding to Keapstone Therapeutics to expand...

Please note that we have now filled the vacant positions on our Drug Discovery Advisory Panel. If you would like to keep up with future...

Parkinson’s UK is pleased to announce the release of the next tranche of the £1million funding to Keapstone Therapeutics. Keapstone...

Parkinson’s UK has held its first ever Drug Discovery Workshop in an effort to unlock new treatments by seeking new ways to progress...

Keapstone Therapeutics, the single-asset virtual biotech created by University of Sheffield with funding from Parkinson’s UK, held a...